DevCurationThe Premier Voice of the Entire Tech Ecosystem
Read Where the Money Moved
Home
Where the Money Moved
News
Events
Investor Spotlight
Company Spotlight
Frameworks
DevCuration
Home
Where the Money Moved
News
Events
Investor Spotlight
Company Spotlight
Frameworks
DevCuration
Latest
Craif Raises $33M Series D for U.S. Cancer Test Push|Queen One Raises $25M to Challenge Legacy Commerce CRM|Network Bio Raises $50M for Patient-Tissue AI|Peppy Closes Pre-Seed Round for Robotics Platform|Twin1 AI Raises $20M for Enterprise Digital Twins|Serif Health Secures Minority Investment From SEVA|Codio Raises $5M to Expand AI Literacy in Higher Education|OpenAI Acquires Rockset for Real-Time AI Retrieval|FSH Technologies Raises $20M Series A for GovTech|idler Raises $9M to Build AI Training Environments|Craif Raises $33M Series D for U.S. Cancer Test Push|Queen One Raises $25M to Challenge Legacy Commerce CRM|Network Bio Raises $50M for Patient-Tissue AI|Peppy Closes Pre-Seed Round for Robotics Platform|Twin1 AI Raises $20M for Enterprise Digital Twins|Serif Health Secures Minority Investment From SEVA|Codio Raises $5M to Expand AI Literacy in Higher Education|OpenAI Acquires Rockset for Real-Time AI Retrieval|FSH Technologies Raises $20M Series A for GovTech|idler Raises $9M to Build AI Training Environments
DevCuration

The premier voice of the tech ecosystem, from ideation to enterprise.

Explore

  • Where the Money Moved
  • Events
  • Articles & Analysis

Spotlights

  • Investor Spotlight
  • Company Spotlight
  • Frameworks

Company

  • About Us
  • Privacy Policy
  • Terms of Service
© 2026 DevCuration. All rights reserved.
TwitterLinkedIn
Logos provided by Logo.dev
Back to Ecosystem Intelligence
BlueWind Medical

BlueWind Medical

Developing implantable tibial neuromodulation systems for urgency urinary incontinence.

UnknownEarly Stage
Total Funding
—
Employees
—
Headquarters
Salt Lake City, Utah
Founded
—

About

Categories

Funding History

Round
Amount
Date
Lead Investors
combined equity and debt financing
$47.8M
January 1, 2026
combined equity and debt financing
$47.8M
January 1, 2026